elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53569776-275DB776-A364-4367-A2C7-723A50CE0B7B
Q53569776-275DB776-A364-4367-A2C7-723A50CE0B7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53569776-275DB776-A364-4367-A2C7-723A50CE0B7B
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
P2860
Q53569776-275DB776-A364-4367-A2C7-723A50CE0B7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53569776-275DB776-A364-4367-A2C7-723A50CE0B7B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d19fb5072998da5a7173cf140d8b1e70e115f3d
P2860
The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.